MAP2K3 and Alzheimer disease: Genetic differences include lower rates of the apolipoprotein ε4 allele which is associated with an increased risk of Alzheimer's disease (AD)17 as well as variants in the Mitogen‐Activated Protein Kinase 3 (MAP2K3) gene.18